Inmune Bio INMB
INmune Bio Inc. Announces Second Quarter 2025 Results
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001213900-25-073089
- Document
- 8-K
- Exhibit 99.1
- Press release, dated August 7, 2025
- Reports quarterly results (2.02)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2836) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.
- Metagenomi Therapeutics MGX public float $51M, Jun 30, 2025
- Invivyd IVVD public float $51M, Jun 30, 2025
- Greenland Mines GRML public float $53M, Jun 30, 2025
- Senti Biosciences Holdings SNTI public float $53M, Jun 30, 2025
- Precision Biosciences DTIL public float $47M, Jun 30, 2025
